{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:21Z","timestamp":1792791441371,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK119762"],"award-info":[{"award-number":["R01DK119762"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK139694"],"award-info":[{"award-number":["R01DK139694"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Augusta University Intramural Pilots Project","id":[{"id":"https:\/\/ror.org\/012mef835","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-07424-7","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T18:07:48Z","timestamp":1736186868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Transsulfuration pathway activation attenuates oxidative stress and ferroptosis in sickle primary erythroblasts and transgenic mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Caixia","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9982-8013","authenticated-orcid":false,"given":"Junfeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weinan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1137-3390","authenticated-orcid":false,"given":"Huidong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-7208","authenticated-orcid":false,"given":"Anatolij","family":"Horuzsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty S.","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7039-4541","authenticated-orcid":false,"given":"Xingguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"7424_CR1","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJM199410133311515","volume":"331","author":"GP Rodgers","year":"1994","unstructured":"Rodgers, G. P., Walker, E. C. & Podgor, M. J. Mortality in sickle cell disease. N. Engl. J. Med. 331, 1022\u20131023 (1994).","journal-title":"N. Engl. J. Med."},{"key":"7424_CR2","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees, D. C., Williams, T. N. & Gladwin, M. T. Sickle-cell disease. Lancet 376, 2018\u20132031 (2010).","journal-title":"Lancet"},{"key":"7424_CR3","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1182\/blood-2010-07-299636","volume":"117","author":"D Darghouth","year":"2011","unstructured":"Darghouth, D. et al. Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome. Blood 117, e57\u2013e66 (2011).","journal-title":"Blood"},{"key":"7424_CR4","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1111\/trf.14931","volume":"58","author":"R Culp-Hill","year":"2018","unstructured":"Culp-Hill, R. et al. Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism. Transfusion 58, 2797\u20132806 (2018).","journal-title":"Transfusion"},{"key":"7424_CR5","first-page":"e2009006","volume":"1","author":"R Mariani","year":"2009","unstructured":"Mariani, R., Trombini, P., Pozzi, M. & Piperno, A. Iron metabolism in thalassemia and sickle cell disease. Mediterr. J. Hematol. Infect. Dis. 1, e2009006 (2009).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"7424_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/pbc.25297","volume":"62","author":"GJ Kato","year":"2015","unstructured":"Kato, G. J. Defective nitric oxide metabolism in sickle cell disease. Pediatr. Blood Cancer 62, 373\u2013374 (2015).","journal-title":"Pediatr. Blood Cancer"},{"key":"7424_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3656717","volume":"2020","author":"T Klouda","year":"2020","unstructured":"Klouda, T., Raybagkar, D., Bernstein, B. & Apollonsky, N. Changes in Blood Profile from Steady State in Patients with Sickle Cell Anemia Admitted for Vaso-occlusive Crisis and Acute Chest Syndrome. Adv. Hematol. 2020, 3656717 (2020).","journal-title":"Adv. Hematol."},{"key":"7424_CR8","doi-asserted-by":"publisher","unstructured":"Cardoso, E. C. et al. Changes in heme levels during acute vaso-occlusive crisis in sickle cell anemia. Hematol. Oncol. Stem Cell Ther. https:\/\/doi.org\/10.1016\/j.hemonc.2021.08.002 (2021).","DOI":"10.1016\/j.hemonc.2021.08.002"},{"key":"7424_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01702-8","volume":"11","author":"H Abdulwahab","year":"2021","unstructured":"Abdulwahab, H. et al. Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease. Sci. Rep. 11, 22199 (2021).","journal-title":"Sci. Rep."},{"key":"7424_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.freeradbiomed.2013.08.181","volume":"65","author":"DGH Silva","year":"2013","unstructured":"Silva, D. G. H., Belini Junior, E., de Almeida, E. A. & Bonini-Domingos, C. R. Oxidative stress in sickle cell disease: an overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies. Free Radic. Biol. Med 65, 1101\u20131109 (2013).","journal-title":"Free Radic. Biol. Med"},{"key":"7424_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MOH.0b013e32835f55f9","volume":"20","author":"K Sun","year":"2013","unstructured":"Sun, K. & Xia, Y. New insights into sickle cell disease: a disease of hypoxia. Curr. Opin. Hematol. 20, 215\u2013221 (2013).","journal-title":"Curr. Opin. Hematol."},{"key":"7424_CR12","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.1152\/ajpendo.00287.2005","volume":"291","author":"M Reid","year":"2006","unstructured":"Reid, M., Badaloo, A., Forrester, T. & Jahoor, F. In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease. Am. J. Physiol. Endocrinol. Metab. 291, E73\u2013E79 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"7424_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0899-9007(98)00060-4","volume":"15","author":"J Faintuch","year":"1999","unstructured":"Faintuch, J., Aguilar, P. B. & Nadalin, W. Relevance of N-acetylcysteine in clinical practice: fact, myth or consequence? Nutrition 15, 177\u2013179 (1999).","journal-title":"Nutrition"},{"key":"7424_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ajh.10321","volume":"73","author":"BS Pace","year":"2003","unstructured":"Pace, B. S. et al. Effects of N-acetylcysteine on dense cell formation in sickle cell disease. Am. J. Hematol. 73, 26\u201332 (2003).","journal-title":"Am. J. Hematol."},{"key":"7424_CR15","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00277-011-1404-z","volume":"91","author":"E Nur","year":"2012","unstructured":"Nur, E. et al. N-acetylcysteine reduces oxidative stress in sickle cell patients. Ann. Hematol. 91, 1097\u20131105 (2012).","journal-title":"Ann. Hematol."},{"key":"7424_CR16","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cmet.2019.09.009","volume":"30","author":"J Zhu","year":"2019","unstructured":"Zhu, J. et al. Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation. Cell Metab. 30, 865\u2013876 e865 (2019).","journal-title":"Cell Metab."},{"key":"7424_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41416-019-0660-x","volume":"122","author":"N Liu","year":"2020","unstructured":"Liu, N., Lin, X. & Huang, C. Activation of the reverse transsulfuration pathway through NRF2\/CBS confers erastin-induced ferroptosis resistance. Br. J. Cancer 122, 279\u2013292 (2020).","journal-title":"Br. J. Cancer"},{"key":"7424_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1042\/bj3570097","volume":"357","author":"Y Ge","year":"2001","unstructured":"Ge, Y., Konrad, M. A., Matherly, L. H. & Taub, J. W. Transcriptional regulation of the human cystathionine beta-synthase -1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1\/Sp3. Biochem. J. 357, 97\u2013105 (2001).","journal-title":"Biochem. J."},{"key":"7424_CR19","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1172\/JCI64578","volume":"123","author":"S Ghosh","year":"2013","unstructured":"Ghosh, S. et al. Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J. Clin. Invest 123, 4809\u20134820 (2013).","journal-title":"J. Clin. Invest"},{"key":"7424_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.561917","volume":"11","author":"OT Gbotosho","year":"2020","unstructured":"Gbotosho, O. T., Kapetanaki, M. G. & Kato, G. J. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease. Front. Immunol. 11, 561917 (2020).","journal-title":"Front. Immunol."},{"key":"7424_CR21","doi-asserted-by":"publisher","first-page":"e0196455","DOI":"10.1371\/journal.pone.0196455","volume":"13","author":"JD Belcher","year":"2018","unstructured":"Belcher, J. D. et al. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction. PLoS One 13, e0196455 (2018).","journal-title":"PLoS One"},{"key":"7424_CR22","doi-asserted-by":"publisher","unstructured":"Merle, N. S. et al. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles. JCI Insight 3, https:\/\/doi.org\/10.1172\/jci.insight.96910 (2018).","DOI":"10.1172\/jci.insight.96910"},{"key":"7424_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1089\/ars.2015.6571","volume":"26","author":"JD Belcher","year":"2017","unstructured":"Belcher, J. D. et al. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate. Antioxid. Redox Signal 26, 748\u2013762 (2017).","journal-title":"Antioxid. Redox Signal"},{"key":"7424_CR24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/blood-2023-182389","volume":"142","author":"C Xi","year":"2023","unstructured":"Xi, C. et al. Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease. Blood 142, 382\u2013396 (2023).","journal-title":"Blood"},{"key":"7424_CR25","doi-asserted-by":"publisher","unstructured":"Krishnamoorthy, S. et al. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease. JCI Insight 2, https:\/\/doi.org\/10.1172\/jci.insight.96409 (2017).","DOI":"10.1172\/jci.insight.96409"},{"key":"7424_CR26","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s42003-023-05443-4","volume":"6","author":"MC Ocana","year":"2023","unstructured":"Ocana, M. C. et al. New insights in the targets of action of dimethyl fumarate in endothelial cells: effects on energetic metabolism and serine synthesis in vitro and in vivo. Commun. Biol. 6, 1084 (2023).","journal-title":"Commun. Biol."},{"key":"7424_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-163","volume":"9","author":"P Albrecht","year":"2012","unstructured":"Albrecht, P. et al. Effects of dimethyl fumarate on neuroprotection and immunomodulation. J. Neuroinflammation 9, 163 (2012).","journal-title":"J. Neuroinflammation"},{"key":"7424_CR28","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1073\/pnas.1603907113","volume":"113","author":"U Schulze-Topphoff","year":"2016","unstructured":"Schulze-Topphoff, U. et al. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. Proc. Natl Acad. Sci. USA 113, 4777\u20134782 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7424_CR29","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1074\/mcp.RA118.000922","volume":"18","author":"GG Piroli","year":"2019","unstructured":"Piroli, G. G. et al. Identification of Novel Protein Targets of Dimethyl Fumarate Modification in Neurons and Astrocytes Reveals Actions Independent of Nrf2 Stabilization. Mol. Cell Proteom. 18, 504\u2013519 (2019).","journal-title":"Mol. Cell Proteom."},{"key":"7424_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11139-3","volume":"10","author":"KE Carlstrom","year":"2019","unstructured":"Carlstrom, K. E. et al. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes. Nat. Commun. 10, 3081 (2019).","journal-title":"Nat. Commun."},{"key":"7424_CR31","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.3324\/haematol.2016.160788","volume":"102","author":"X Zhu","year":"2017","unstructured":"Zhu, X., Li, B. & Pace, B. S. NRF2 mediates gamma-globin gene regulation and fetal hemoglobin induction in human erythroid progenitors. Haematologica 102, e285\u2013e288 (2017).","journal-title":"Haematologica"},{"key":"7424_CR32","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato, G. J., Steinberg, M. H. & Gladwin, M. T. Intravascular hemolysis and the pathophysiology of sickle cell disease. J. Clin. Invest 127, 750\u2013760 (2017).","journal-title":"J. Clin. Invest"},{"key":"7424_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1165\/rcmb.2009-0307OC","volume":"44","author":"CL Grek","year":"2011","unstructured":"Grek, C. L., Newton, D. A., Spyropoulos, D. D. & Baatz, J. E. Hypoxia up-regulates expression of hemoglobin in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 44, 439\u2013447 (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"7424_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41586-022-05312-w","volume":"610","author":"R Feng","year":"2022","unstructured":"Feng, R. et al. Activation of gamma-globin expression by hypoxia-inducible factor 1alpha. Nature 610, 783\u2013790 (2022).","journal-title":"Nature"},{"key":"7424_CR35","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1182\/blood-2014-07-591453","volume":"125","author":"J Xiang","year":"2015","unstructured":"Xiang, J., Wu, D. C., Chen, Y. & Paulson, R. F. In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors. Blood 125, 1803\u20131812 (2015).","journal-title":"Blood"},{"key":"7424_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ymgme.2022.08.004","volume":"137","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Amino acid signature during sickle cell pain crisis shows significant alterations related to nitric oxide and energy metabolism. Mol. Genet Metab. 137, 146\u2013152 (2022).","journal-title":"Mol. Genet Metab."},{"key":"7424_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma, Q. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharm. Toxicol. 53, 401\u2013426 (2013).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"7424_CR38","doi-asserted-by":"publisher","first-page":"D110","DOI":"10.1093\/nar\/gkv1176","volume":"44","author":"A Mathelier","year":"2016","unstructured":"Mathelier, A. et al. JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 44, D110\u2013D115 (2016).","journal-title":"Nucleic Acids Res."},{"key":"7424_CR39","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2019\/e630","volume":"74","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. CBS promoter hypermethylation increases the risk of hypertension and stroke. Clinics 74, e630 (2019).","journal-title":"Clinics"},{"key":"7424_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep15217","volume":"5","author":"QY Cheng","year":"2015","unstructured":"Cheng, Q. Y. et al. Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography\/Mass Spectrometry Analysis. Sci. Rep. 5, 15217 (2015).","journal-title":"Sci. Rep."},{"key":"7424_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102175","volume":"48","author":"H Zheng","year":"2021","unstructured":"Zheng, H., Jiang, L., Tsuduki, T., Conrad, M. & Toyokuni, S. Embryonal erythropoiesis and aging exploit ferroptosis. Redox Biol. 48, 102175 (2021).","journal-title":"Redox Biol."},{"key":"7424_CR42","first-page":"497","volume":"32","author":"B Brune","year":"1987","unstructured":"Brune, B. & Ullrich, V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol. Pharm. 32, 497\u2013504 (1987).","journal-title":"Mol. Pharm."},{"key":"7424_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/89068","volume":"7","author":"HJ Duckers","year":"2001","unstructured":"Duckers, H. J. et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7, 693\u2013698 (2001).","journal-title":"Nat. Med."},{"key":"7424_CR44","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1161\/CIRCRESAHA.116.306588","volume":"118","author":"LE Otterbein","year":"2016","unstructured":"Otterbein, L. E., Foresti, R. & Motterlini, R. Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival. Circ. Res. 118, 1940\u20131959 (2016).","journal-title":"Circ. Res."},{"key":"7424_CR45","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1172\/JCI26857","volume":"116","author":"JD Belcher","year":"2006","unstructured":"Belcher, J. D. et al. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J. Clin. Invest 116, 808\u2013816 (2006).","journal-title":"J. Clin. Invest"},{"key":"7424_CR46","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008455","author":"AV Menon","year":"2021","unstructured":"Menon, A. V. et al. Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease. Blood https:\/\/doi.org\/10.1182\/blood.2020008455 (2021).","journal-title":"Blood"},{"key":"7424_CR47","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","volume":"186","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Human hematopoietic stem cell vulnerability to ferroptosis. Cell 186, 732\u2013747 e716 (2023).","journal-title":"Cell"},{"key":"7424_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood-2015-06-654194","volume":"127","author":"O Canli","year":"2016","unstructured":"Canli, O. et al. Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood 127, 139\u2013148 (2016).","journal-title":"Blood"},{"key":"7424_CR49","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/febs.16382","volume":"290","author":"H Nishizawa","year":"2023","unstructured":"Nishizawa, H., Yamanaka, M. & Igarashi, K. Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal. FEBS J. 290, 1688\u20131704 (2023).","journal-title":"FEBS J."},{"key":"7424_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.exphem.2017.02.003","volume":"50","author":"R Jagadeeswaran","year":"2017","unstructured":"Jagadeeswaran, R. et al. Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. Exp. Hematol. 50, 46\u201352 (2017).","journal-title":"Exp. Hematol."},{"key":"7424_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.exphem.2023.02.005","volume":"122","author":"A Gallivan","year":"2023","unstructured":"Gallivan, A. et al. Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia. Exp. Hematol. 122, 55\u201362 (2023).","journal-title":"Exp. Hematol."},{"key":"7424_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1984-4","volume":"10","author":"TX Wang","year":"2019","unstructured":"Wang, T. X. et al. The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis. Cell Death Dis. 10, 755 (2019).","journal-title":"Cell Death Dis."},{"key":"7424_CR53","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1080\/15384101.2022.2155016","volume":"22","author":"D Qi","year":"2023","unstructured":"Qi, D. et al. Dimethyl fumarate protects against hepatic ischemia-reperfusion injury by alleviating ferroptosis via the NRF2\/SLC7A11\/HO-1 axis. Cell Cycle 22, 818\u2013828 (2023).","journal-title":"Cell Cycle"},{"key":"7424_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.382","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. Dimethyl fumarate prevents ferroptosis to attenuate acute kidney injury by acting on NRF2. Clin. Transl. Med 11, e382 (2021).","journal-title":"Clin. Transl. Med"},{"key":"7424_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7001","volume":"6","author":"L Zheng","year":"2015","unstructured":"Zheng, L. et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat. Commun. 6, 6001 (2015).","journal-title":"Nat. Commun."},{"key":"7424_CR56","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1182\/blood.2020009404","volume":"138","author":"A Schmitt","year":"2021","unstructured":"Schmitt, A. et al. Dimethyl fumarate induces ferroptosis and impairs NF-kappaB\/STAT3 signaling in DLBCL. Blood 138, 871\u2013884 (2021).","journal-title":"Blood"},{"key":"7424_CR57","doi-asserted-by":"publisher","unstructured":"Singhal, R. et al. HIF-2alpha activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron. J. Clin. Invest. 131, https:\/\/doi.org\/10.1172\/JCI143691 (2021).","DOI":"10.1172\/JCI143691"},{"key":"7424_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06602-z","volume":"15","author":"ME Mantione","year":"2024","unstructured":"Mantione, M. E. et al. Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death. Cell Death Dis. 15, 224 (2024).","journal-title":"Cell Death Dis."},{"key":"7424_CR59","volume":"2011","author":"AH Al-Salem","year":"2011","unstructured":"Al-Salem, A. H. Splenic complications of sickle cell anemia and the role of splenectomy. ISRN Hematol. 2011, 864257 (2011).","journal-title":"ISRN Hematol."},{"key":"7424_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/pr.2016.204","volume":"81","author":"ER Meier","year":"2017","unstructured":"Meier, E. R. & Rampersad, A. Pediatric sickle cell disease: past successes and future challenges. Pediatr. Res 81, 249\u2013258 (2017).","journal-title":"Pediatr. Res"},{"key":"7424_CR61","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cgh.2010.02.016","volume":"8","author":"EC Ebert","year":"2010","unstructured":"Ebert, E. C., Nagar, M. & Hagspiel, K. D. Gastrointestinal and hepatic complications of sickle cell disease. Clin. Gastroenterol. Hepatol. 8, 483\u2013489 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"7424_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ppedcard.2019.101192","volume":"56","author":"SA Noronha","year":"2020","unstructured":"Noronha, S. A. Cardiac causes of hypoxia in sickle cell disease. Prog. Pediatr. Cardiol. 56, 101192 (2020).","journal-title":"Prog. Pediatr. Cardiol."},{"key":"7424_CR63","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2017-10-810531","volume":"131","author":"X Zhu","year":"2018","unstructured":"Zhu, X., Xi, C., Thomas, B. & Pace, B. S. Loss of NRF2 function exacerbates the pathophysiology of sickle cell disease in a transgenic mouse model. Blood 131, 558\u2013562 (2018).","journal-title":"Blood"},{"key":"7424_CR64","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1177\/1535370220945305","volume":"245","author":"X Zhu","year":"2020","unstructured":"Zhu, X. et al. NRF2 mediates gamma-globin gene regulation through epigenetic modifications in a beta-YAC transgenic mouse model. Exp. Biol. Med. 245, 1308\u20131318 (2020).","journal-title":"Exp. Biol. Med."},{"key":"7424_CR65","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1126\/science.278.5339.873","volume":"278","author":"TM Ryan","year":"1997","unstructured":"Ryan, T. M., Ciavatta, D. J. & Townes, T. M. Knockout-transgenic mouse model of sickle cell disease. Science 278, 873\u2013876 (1997).","journal-title":"Science"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07424-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07424-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07424-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T19:02:47Z","timestamp":1736190167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07424-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7424"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-07424-7","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}